IP Verse

Curevac competitive analysis

Loading summary...

Latest patents of Curevac opposed by its competitors

Explore Curevac's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3090060
May 21, 2025Methods For Rna Analysis1
EP3283059
Jan 3, 2024Method For Producing Rna Compositions7
EP4155409
Dec 27, 2023Method Of Increasing The Replication Of A Circular Dna Molecule4
EP4108769
Aug 30, 2023A Method For Producing And Purifying Rna, Comprising At Least One Step Of Tangential Flow Filtration5
EP4023755
Apr 26, 2023Artificial Nucleic Acid Molecules For Improved Protein Expression4
EP3521456
Jan 4, 2023Methods And Means For Enhancing Rna Production3
EP3708668
Jul 27, 2022Artificial Nucleic Acid Molecules For Improved Protein Expression4
EP3283125
Dec 29, 2021Lyophilization Of Rna2
EP3115064
Nov 24, 2021Rna-Coded Antibody1
EP2680880
Nov 10, 2021Vaccination In Newborns And Infants1

Latest publications and patents of Curevac New

Explore the latest publications and patents granted to Curevac, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Curevac

EP3090060
May 21, 2025Methods For Rna AnalysisPatent Maintained As Amended
EP3283059
Jan 3, 2024Method For Producing Rna CompositionsRevoked
EP4155409
Dec 27, 2023Method Of Increasing The Replication Of A Circular Dna MoleculeGranted And Under Opposition
EP4108769
Aug 30, 2023A Method For Producing And Purifying Rna, Comprising At Least One Step Of Tangential Flow FiltrationGranted And Under Opposition
EP4023755
Apr 26, 2023Artificial Nucleic Acid Molecules For Improved Protein ExpressionGranted And Under Opposition
EP3521456
Jan 4, 2023Methods And Means For Enhancing Rna ProductionRevoked
EP3708668
Jul 27, 2022Artificial Nucleic Acid Molecules For Improved Protein ExpressionGranted And Under Opposition
EP3283125
Dec 29, 2021Lyophilization Of RnaRevoked
EP3115064
Nov 24, 2021Rna-Coded AntibodyGranted And Under Opposition
EP2680880
Nov 10, 2021Vaccination In Newborns And InfantsPatent Maintained As Amended

Latest PTAB cases involving Curevac

Discover the latest PTAB cases involving Curevac, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 24, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Curevac

IPR2017-02194Sep 29, 2017MODERNACUREVACFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Curevac with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CUREVAC - 62 - 1
BIONTECH3061 -
SANOFI5923 - -
STRAWMAN336 - - -